Metabolomic Discoveries launches personalized metabolomics service Kenkodo through crowdfunding platform Indiegogo

German biotech company Metabolomic Discoveries announced the launch of personalized metabolomics tool Kenkodo. Through a smartphone app and sampling kit, users will soon be able to improve their well­being. Kenkodo is available through the crowdfunding platform Indiegogo. This product offers people the possibility to track and understand the influence of factors, such as nutrition, sports and stress on their metabolism. Through lifestyle changes, shifts in the metabolism become measurable and can be optimized accordingly. Kenkodo builds the biochemical fingerprint of every single participant.

Dr. Nicolas Schauer, CEO of Metabolomic Discoveries, is very excited about the development of Kenkodo. "Over the last couple of years we have gained a lot of knowledge and experience in metabolomics technology. It tracks more than 1000 small molecules in human samples. Metabolomics has the potential to resolve many questions regarding your wellness and your general constitution. Kenkodo will empower people to understand the effect of their daily lifestyle habits on their body. And finally, to find a lifestyle that keeps them healthy."

Every human has a different, very individual biochemical fingerprint. It combines information about our body's building blocks like amino acids or lipids and is the ultimate indicator of our level of well­being. “People respond differently to food, beverages and sports. By analyzing the metabolome of a large group of people, we will be able to make links to their lifestyle and well­being and draw meaningful conclusions, for example about food intake." says Dr. Josephine Worseck, Head of Business Development at Metabolomic Discoveries.

Dr. Isam Haddad, Bioinformatics expert at Metabolomic Discoveries, commented about Kenkodo. "We will build a predictive model that relates your lifestyle habits to your body's response. Our vision is that people will ultimately be able to recognize the metabolic pattern of a great week and repeat it by using the knowledge of Kenkodo."

For further information, please visit Kenkodo's Indiegogo campaign:
https://www.indiegogo.com/projects/track-your-metabolism-to-a-healthier-life-kenkodo

About Metabolomic Discoveries
Metabolomic Discoveries is a leading research and analytical service company. Global metabolite analysis combined with high­performance computing enables the identification of patterns. This provides deep insights into metabolism and allows to develop prediction models to live a better and healthier life.

Most Popular Now

Xenpozyme™ (olipudase alfa-rpcp) approved by FDA a…

The U.S. Food and Drug Administration (FDA) has approved Xenpozyme™ (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid...

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Research reveals widespread use of ineffective COV…

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

Efficacy, cash and more will increase booster shot…

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine (COMIRNATY® Original/Om...